Determination of doxorubicin and doxorubicinol in plasma of cancer patients by high-performance liquid chromatography.
about
Increased efficacy of doxorubicin delivered in multifunctional microparticles for mesothelioma therapyA mechanistic study of the effect of doxorubicin/adriamycin on the estrogen response in a breast cancer modelQuantification of Doxorubicin and metabolites in rat plasma and small volume tissue samples by liquid chromatography/electrospray tandem mass spectroscopy.Microspheres targeted with a mesothelin antibody and loaded with doxorubicin reduce tumor volume of human mesotheliomas in xenograftsMonitoring subcellular biotransformation of N-L-leucyldoxorubicin by micellar electrokinetic capillary chromatography coupled to laser-induced fluorescence detection.Multi-channel cell co-culture for drug development based on glass microfluidic chip-mass spectrometry coupled platform.The human organic cation transporter OCT1 mediates high affinity uptake of the anticancer drug daunorubicinA Simple and Sensitive HPLC Method for Fluorescence Quantitation of Doxorubicin in Micro-volume Plasma: Applications to Pharmacokinetic Studies in Rats.Determination of anthracycline antibiotics doxorubicin and daunorubicin by capillary electrophoresis with UV absorption detection.Correlation of toxicity and efficacy with pharmacokinetics (PK) of pegylated liposomal doxorubicin (PLD) (Caelyx®).Quantification of doxorubicin in biofluids using white light excitation fluorescence.Detection of doxorubicin in the horny layer in a patient suffering from palmar-plantar erythrodysaesthesia.Reversing the undesirable pH-profile of doxorubicin via activation of a di-substituted maleamic acid prodrug at tumor acidity.
P2860
Q28385656-99E97E1B-F81E-4A35-9607-5E11E00888F0Q30417300-BDA4F068-7B74-4A32-9DA1-160AF658C2DAQ33958482-D503275F-26D5-4470-8711-563277865DF5Q34984956-3C62E8DF-CD4F-4BD2-953C-5E0EF00FB172Q35103568-23B32B26-253B-4B4A-A80B-958963928DFEQ36107621-145D23BF-C2F2-4A9B-A47D-08188E731CCDQ36564944-E83AE5B9-3E12-474D-A981-5CA9F3099794Q41117864-7A0C316C-5C0F-45FE-BBCE-F531F1233459Q43729867-A20DD280-9A48-4D94-A52F-AD720A7EB186Q44196403-0527D044-A5E6-44C6-BAF4-29CCD9C1DA41Q46108783-5C5DD5D0-BEDC-4BD9-B3C9-2D0C5B9884C3Q46398847-0F6AB8AC-1434-4E7E-B1FB-1249D90B05DEQ49979334-2F502F1F-752D-419D-94B2-11CE793D2614
P2860
Determination of doxorubicin and doxorubicinol in plasma of cancer patients by high-performance liquid chromatography.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Determination of doxorubicin a ...... ormance liquid chromatography.
@en
type
label
Determination of doxorubicin a ...... ormance liquid chromatography.
@en
prefLabel
Determination of doxorubicin a ...... ormance liquid chromatography.
@en
P2093
P356
P1476
Determination of doxorubicin a ...... ormance liquid chromatography.
@en
P2093
Planting AS
Sparreboom A
de Bruijn P
P304
P356
10.1006/ABIO.1998.2943
P407
P577
1999-01-01T00:00:00Z